Search results
Gilead Has A Narrative-Changing Revelation For Its Weight-Loss Contender
Investor's Business Daily· 11 minutes agoGilead Stock: Big Competition In MASH Treatment The first treatment for MASH gained Food and Drug...
Regeneron touts success with bispecific antibody in multiple myeloma trial
Clinical Trials Arena via Yahoo Finance· 4 hours agoRegeneron said that the therapy is under review by the US Food and Drug Administration. In addition,...
New drug's potentially fatal side effects obscured by 'soothing acronym,' doctors say
Los Angeles Times· 10 hours agoSeventy-nine-year-old Genevieve Lane volunteered to take the Alzheimer’s drug Leqembi in a clinical...
Milestone for Biotest: US Approval for Innovative Immunoglobulin Yimmugo
NewMediaWire via Yahoo Finance· 51 minutes agoFDA approval secures significant future sales and earnings growth through entry into the world's...
How a well-traveled brain cancer drug turned into an $8 million payday for an East Bay firm - San...
The Business Journals· 2 hours agoA drug traded between companies for 20 years — and approved by regulators in April to treat brain...
FDA grants approval for Bristol Myers Squibb’s Augtyro for solid tumours
Pharmaceutical Technology via Yahoo Finance· 14 hours agoThe US Food and Drug Administration (FDA) has granted accelerated approval for Bristol Myers...
Drug testing, Philly parks, and other opioid money decisions await final approval
WFMZ Eastern Pennsylvania and Western New Jersey· 2 hours agoSpotlight PA is an independent, nonpartisan, and nonprofit newsroom producing investigative and...
AstraZeneca’s lung cancer drug approved by US FDA for combination chemotherapy treatment | Invezz
Invezz· 8 hours agoAstraZeneca, the largest pharmaceutical group in Britain, announced that the U.S. Food and Drug...
Novavax seeks FDA approval for updated Covid-19 vaccine
Pharmaceutical Technology via Yahoo Finance· 12 hours agoNovavax has submitted an application to the US Food and Drug Administration (FDA) seeking approval...
A new drug could slow Alzheimer's: But can patients get it?
Medical Xpress· 6 hours agodrug to target amyloid plaques in the brain, which have been associated with the memory-destroying disease. In weighing Lilly's data for donanemab, the FDA's advisers didn't ...